VANGUARD GROUP INC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$951,782
-84.1%
5,172,726
+3.5%
0.00%
Q2 2023$5,972,189
+72.2%
4,997,648
-0.4%
0.00%
Q1 2023$3,467,571
+1.8%
5,016,7410.0%0.00%
Q4 2022$3,406,367
-34.0%
5,016,741
+0.0%
0.00%
Q3 2022$5,164,000
+54.1%
5,014,340
+1.8%
0.00%
Q2 2022$3,352,000
-29.2%
4,927,350
-12.8%
0.00%
Q1 2022$4,735,000
-43.6%
5,650,988
+9.8%
0.00%
Q4 2021$8,389,000
-32.8%
5,146,483
-0.6%
0.00%
Q3 2021$12,478,000
-1.5%
5,177,503
+7.9%
0.00%
Q2 2021$12,673,000
-13.1%
4,800,323
+64.3%
0.00%
Q1 2021$14,577,000
+229.6%
2,921,164
+4.3%
0.00%
Q4 2020$4,423,000
+859.4%
2,799,854
+469.7%
0.00%
Q3 2020$461,000
+51.1%
491,487
+63.0%
0.00%
Q2 2020$305,000
+93.0%
301,588
-6.1%
0.00%
Q1 2020$158,000
-50.8%
321,185
+34.3%
0.00%
Q4 2019$321,000
+45.9%
239,2220.0%0.00%
Q3 2019$220,000
-58.0%
239,2220.0%0.00%
Q2 2019$524,000
+33.0%
239,222
+104.2%
0.00%
Q1 2019$394,000117,1360.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders